As of Mar 05
| +0.29 / +5.13%|
The 1 analysts offering 12-month price forecasts for Fibrocell Science Inc have a median target of 9.25, with a high estimate of 9.25 and a low estimate of 9.25. The median estimate represents a +55.72% increase from the last price of 5.94.
The current consensus among 1 polled investment analysts is to Buy stock in Fibrocell Science Inc. This rating has held steady since March, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.